ESCRS - Knowing the risk factors can help in planning treatment of glaucoma patients

Knowing the risk factors can help in planning treatment of glaucoma patients

Knowing the risk factors can help in planning treatment of glaucoma  patients

High IOP, advanced age, disc haemorrhage, and a history of disease progression, are the

main factors predictive of progression in patients with, glaucoma. However, many factors

that figure strongly in glaucoma onset appear to have no influence on disease

progression, said Anders Heijl MD, Skåne University Hospital Malmö, Malmö, Sweden.

“Knowledge about the risk factors for glaucoma progression is important because when

we have risk factors than we probably also need lower target intraocular pressure. And

more importantly, patients with risk factors need to be followed more frequently than

patients without risk factors for progression,” Dr Heijl told the 11

Society Congress in Nice.

He noted that several large randomised trials, including the Early Manifest Glaucoma

treatment study (EMGT) and the Advanced Glaucoma Intervention Study (AGIS) have

shown a clear association between elevated IOP and disease progression. However,

there is no evidence that broad IOP fluctuation is an independent risk factor for glaucoma

progression.

Evidence is also weak at best for any association between glaucoma progression and

central corneal thickness, refractive error, and ocular perfusion pressure, although there

is good evidence for all those factors and glaucoma onset.

Meanwhile, the studies show that advanced age doubles the risk of progression and that

disc haemorrhage increases the risk 26­fold. A history of progression is also a good

predictor of future progression.

He added that, apart from adhering to their IOP lowering regimen, there unfortunately

doesn’t appear to be a lot that glaucoma patients themselves can do to reduce their risk

of glaucoma progression, Dr Heijl said.

“There is no evidence that any lifestyle factors influence the risk of glaucoma progression.

There is also a lot of talk about general health. For example, Cardiovascular disease,

blood pressure, and diabetes are often discussed and there's a lot of publications in

support of that view, but there's really no clear­cut scientific evidence,” he added.

END

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...